| 產品名稱 |
Unidentified fungus |
| 商品貨號 |
B244050 |
| Strain Designations |
FD 29315 |
| Application |
produces zaragozic acid A |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
frozen |
| Storage Conditions |
Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section |
| Type Strain |
no |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol® |
no |
| Morphology |
After 8 days on Blakeslee’s Malt Extract agar at 25°C, colony flat, white to grey, with pale pink margins, reverse red-brown, red-brown soluble pigment. Hyphae hyaline or lightly pigmented, guttulate, simple-septate, no sporulation observed. |
| Medium |
ATCC® Medium 325: Malt extract agar (Blakeslee's formula)
ATCC® Medium 200: YM agar or YM broth
|
| Growth Conditions |
Temperature: 24°C
Atmosphere: Typical aerobic |
| Sequenced Data |
18S ribosomal RNA gene, partial sequence; internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; and 28S ribosomal RNA gene, partial sequence
AAGGATCATTACCAATTGCGGGCGAGGCCTAGCCTCCCCGCGAACCTTCTCATCCCTTTATGGTGTACCTTTGTTTCCTCGGCAGGCTTGCCTGCCAGCGAGGACCCCCAACAAACCTTTTTGCAGTAAGAAGTATACGTCTTATCAAAAACAAATCGTTTACAACTTTCAACAATGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAGTGTGAATTGCAGAATTTAGCGAATCATCGAATCTTTGAACGCACATTGCGCCTCTTGGTATTCCATGGGGCACGCCTGTTCGAGCGTCATTTCAACCCTCAAGCACTGCTTGGTGTTGGGCGTCTGTCCCGCCTCTGCGCGTGGACTCGCCTCAAAGTCATTGGCGGCTGTTCCCCTTCGGCTCGTAAGCGCAGCACAGTCAGCGCCCGGAGCTCTGGTGGATGGCGTCCAGCAAGCTATATTTCTAGTCTTGACCTCGGATCAGGTGGGGATACCCGCTGAACTTAAG
D1D2 region of the 28S ribosomal RNA gene
CATATCAATAAGCGGAGGAAAAGAAACCAACAGGGATTGCCTTAGTAACGGCGAGTGAAGCGGCAACAGCTCAAATTTGAAATCTGGCCCTTTTAGGGTCCGAGTTGTAATTTGCAGAGGGTGCTTTGGCGTTAGTAGCGATCTAAGTTCCTTGGAACAGGACGTCACAGAGGGTGAGAATCCCGTACGTGGTTGCTCTACTTTCGCCGTGTAAAGCCCCTTCGACGAGTCGAGTTGTTTGGGAATGCAGCTCTAAATGGGAGGTAAATTTCTTCTAAAGCTAAATACCGGCCAGAGACCGATAGCGCACAAGTAGAGTGATCGAAAGATGAAAAGCACTTTGGAAAGAGAGTCAAAAAGCACGTGAAATTGTTGAAAGGGAAGCGCTTGCAGCCAGACGTGCCTGTAGTTGCTCATCCGGGCTTTTGCCCGGTGCACTCTTCTGCAGGCAGGCCAGCATCAGTTTGGGCGGCTGGATAAAGACCTCTGTCACGTACCTCCCTCCGGGGAGGCCTTATAGGGGAGGTGTCATGCAGCCAGCCCGGACTGAGGTCCGCGCATCTGCTAGGATGCTGGCGTAATGGCTGTAAGCGGC
|
| Name of Depositor |
Pfizer, Inc. |
| U.S. Patent Number |
|
| Isolation |
twigs, Juniperus ashei, near Dripping Springs, TX |
| References |
Dabrah TT, et al. Inhibitor of squalene synthase. US Patent 5,430,055 dated Jul 4 1995
|
